Research & Development

A state-of-the-art pharmaceutical research centre in Canada

The Research & Development centre of Boehringer Ingelheim (Canada) Ltd./Ltée is a large and growing complex of skilled people with the singular mission of discovering innovative medicines for the benefit of patients and healthcare professionals worldwide.

Our research centre is located in Laval, Québec, 20 minutes from Montréal’s Pierre Elliott Trudeau International Airport.  Enjoying proximity to the rich heritage and cultural wealth of Montreal and the year-round recreational opportunities of the Laurentian Mountains, it is within easy reach of major metropolitan centres on the East coast of North America. Since acquiring our research centre in 1988, our facilities have undergone successive expansions in 1997 and 2007, with investments of over $50 million.

We are strongly committed to innovative therapeutic research and development in Canada, and to realizing our vision of providing therapeutic Value Through Innovation. Over 150 scientists are working in our modern facilities and are focused on developing new antiviral agents. A committed team of scientists with a wealth of scientific knowledge and expertise, using state-of-the-art technology is key to our success in creating new therapeutic solutions.